Clinical Trial Update: Study Evaluating Sirolimus in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating sirolimus in kidney transplant recipients has completed, with results posted in 2009. The study also includes graft-ver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Kidney Transplantation

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Graft vs Host Disease, Kidney Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2009-09-07